Alzheimer disease (AD) is the most common form of senile dementia, with no effective treatment available. In a study appearing online on August 11 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation, Howard Weiner and colleagues from Harvard describe a novel immunologic approach for the treatment of AD.
Previous studies utilizing immunization against Abeta, a key pathogenic player in AD, to generate antibodies against Abeta were discontinued because of unacceptable side effects in AD patients.
Here, the researchers use a specific nasal vaccination to decrease AD burden in mice. The vaccine consists of an FDA-approved drug currently used to treat multiple sclerosis (called glatiramer acetate) plus a recently developed nasal adjuvant that has been shown to be safe in humans and activates microglia, cells which then clear beta-amyloid in the brain without evidence of toxic effects.
The findings have both basic and clinically relevant implications. The discovery of a non-antibody mediated method to clear Abeta could be used as a treatment for patients who already are showing signs of AD. Moreover, the compounds used have already been safely tested in humans.
Page: 1 Related biology news :1
Contact: Stacie Bloom
Journal of Clinical Investigation
. Malaria -- Effective insecticide-repellent synergy against mosquito vectors2
. Effective new biodiversity data access portal3
. PET/CT use expands: Effectively diagnosing graft infections4
. Effectiveness of certain antidepressants may be influenced by gene variations of individuals5
. UCF, NIH study: Effective, safe anthrax vaccine can be grown in tobacco plants6
. Effective cancer treatments follow the clock7
. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease8
. Link identified between Alzheimers disease and glaucoma9
. UCF research links proteins, stem cells and potential Alzheimers treatment10
. Journal of Alzheimers Disease achieves significant impact factor11
. Alzheimers prevention role discovered for prions